nitrendipine has been researched along with HbS Disease in 6 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stuart, J | 2 |
| Mojiminiyi, FB | 1 |
| Stone, PC | 2 |
| Culliford, SJ | 2 |
| Ellory, JC | 2 |
| Nash, GB | 3 |
| Horwitz, E | 1 |
| Williamson, P | 1 |
| Puchulu, E | 1 |
| Penniston, JT | 1 |
| Westerman, MP | 1 |
| Schlegel, RA | 1 |
| Millar, B | 1 |
| al Saady, N | 1 |
| Bennett, ED | 1 |
| Evans, J | 1 |
| Bevan, DH | 1 |
| Boghossian, S | 1 |
| Parmar, J | 1 |
| Dormandy, JA | 1 |
| Bevan, D | 1 |
| Ohnishi, ST | 1 |
| Horiuchi, KY | 1 |
| Horiuchi, K | 1 |
| Jurman, ME | 1 |
| Sadanaga, KK | 1 |
6 other studies available for nitrendipine and HbS Disease
| Article | Year |
|---|---|
Additive in vitro effects of anti-sickling drugs.
Topics: Anemia, Sickle Cell; Antisickling Agents; Benzaldehydes; Calcium; Cells, Cultured; Clotrimazole; Dru | 1994 |
Mode of action and comparative efficacy of pharmacological agents that inhibit calcium-dependent dehydration of sickle cells.
Topics: Anemia, Sickle Cell; Azepines; Bepridil; Calcium; Calcium Channel Blockers; Erythrocytes, Abnormal; | 1992 |
Ca2+ accumulation and loss by aberrant endocytic vesicles in sickle erythrocytes.
Topics: Anemia, Sickle Cell; Antibodies; Calcium; Calcium-Transporting ATPases; Cell Membrane; Chlortetracyc | 1992 |
Nitrendipine treatment and blood rheology in patients with sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Erythrocyte Aging; Female; Humans; Male; Nitrendipine; Rheology | 1991 |
Alteration of the mechanical properties of sickle cells by repetitive deoxygenation: role of calcium and the effects of calcium blockers.
Topics: Anemia, Sickle Cell; Calcium; Calcium Channel Blockers; Erythrocyte Deformability; Erythrocytes, Abn | 1989 |
Nitrendipine, nifedipine and verapamil inhibit the in vitro formation of irreversibly sickled cells.
Topics: Adult; Anemia, Sickle Cell; Calcium; Calcium Channel Blockers; Calmodulin; Dehydration; Erythrocytes | 1986 |